Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Yap

Showing results (11-20 of 260) with videos related to

Pageof 26
Sort By:
Oncoscience|June 2, 2018
Combination drug development in BRAF mutant colorectal cancerMichael Lam, Shubham Pant, Timothy A Yap
International Journal of Cancer|December 16, 2017
Precision oncology: East meets WestVivek Subbiah, Jordi Rodon, Timothy A Yap
Therapeutic Advances in Medical Oncology|December 1, 2011
c-MET: an exciting new target for anticancer therapyJohann S de Bono, Timothy A Yap
JCO Precision Oncology|June 12, 2024
Poly(ADP-Ribose) Polymerase Inhibitor Development: Promising Strategies to Move Beyond Approved IndicationsCarlos Torrado, Ruth Plummer, Timothy A Yap
Nature Reviews. Clinical Oncology|July 24, 2019
PARP inhibition - opportunities in pancreatic cancerShubham Pant, Anirban Maitra, Timothy A Yap
Molecular Cancer Therapeutics|May 6, 2010
Targeting the HGF/c-Met axis: state of playTimothy A Yap, Johann S de Bono
JAMA Oncology|January 13, 2018
Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged SwordChad Tang, Wen Jiang, Timothy A Yap
Therapeutic Advances in Medical Oncology|December 1, 2011
Future directions in the evaluation of c-MET-driven malignanciesJohann S de Bono, Timothy A Yap
Trends in Cancer|April 22, 2026
Targeting cyclin-dependent kinases in cancer: emerging therapeutics and clinical strategiesHarold N Tan, Giuseppe Curigliano, Timothy A Yap
Nature Reviews. Clinical Oncology|March 7, 2018
Targeting the PI3K pathway in cancer: are we making headway?Filip Janku, Timothy A Yap, Funda Meric-Bernstam
Pageof 26

Showing results (11-20 of 260) with videos related to

Sort By:
Pageof 26
Oncoscience|June 2, 2018
Combination drug development in BRAF mutant colorectal cancerMichael Lam, Shubham Pant, Timothy A Yap
International Journal of Cancer|December 16, 2017
Precision oncology: East meets WestVivek Subbiah, Jordi Rodon, Timothy A Yap
Therapeutic Advances in Medical Oncology|December 1, 2011
c-MET: an exciting new target for anticancer therapyJohann S de Bono, Timothy A Yap
JCO Precision Oncology|June 12, 2024
Poly(ADP-Ribose) Polymerase Inhibitor Development: Promising Strategies to Move Beyond Approved IndicationsCarlos Torrado, Ruth Plummer, Timothy A Yap
Nature Reviews. Clinical Oncology|July 24, 2019
PARP inhibition - opportunities in pancreatic cancerShubham Pant, Anirban Maitra, Timothy A Yap
Molecular Cancer Therapeutics|May 6, 2010
Targeting the HGF/c-Met axis: state of playTimothy A Yap, Johann S de Bono
JAMA Oncology|January 13, 2018
Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged SwordChad Tang, Wen Jiang, Timothy A Yap
Therapeutic Advances in Medical Oncology|December 1, 2011
Future directions in the evaluation of c-MET-driven malignanciesJohann S de Bono, Timothy A Yap
Trends in Cancer|April 22, 2026
Targeting cyclin-dependent kinases in cancer: emerging therapeutics and clinical strategiesHarold N Tan, Giuseppe Curigliano, Timothy A Yap
Nature Reviews. Clinical Oncology|March 7, 2018
Targeting the PI3K pathway in cancer: are we making headway?Filip Janku, Timothy A Yap, Funda Meric-Bernstam
Pageof 26